References
- FukushimaMOhashiTFujiwaraYSonoyamaKNakanoMCholesterol-lowering effects of maitake (Grifola frondosa) fiber, shiitake (Lentinus edodes) fiber, and enokitake (Flammulina velutipes) fiber in ratsExper Biol Med (Maywood)2001226875876511520942
- GeZWYangZLZhangPMathenyPBHibbettDSFlammulina species from China inferred by morphological and molecular dataFungal Divers2008325968
- TereshinaVMMemorskayaASAdaptation of Flammulina velutipes to hypothermia in natural environments: The role of lipids and carbohydratesMicrobiology2005743279283
- YangJHLinHCMauJLNon-volatile taste components of several commercial mushroomsFood Chem2001724465471
- SongCHJeonYJYangBKRaKSKimHIAnti-complementary activity of endopolymers produced from submerged mycelial culture of higher fungi with particular reference toLentinus edodes Biotechnol Lett1998208741744
- IshikawaNKFukushiYYamajiKTaharaSTakahashiKAntimicrobial cuparene-type sesquiterpenes, enokipodins C and D, from a mycelial culture of Flammulina velutipesJ Nat Prod200164793293411473426
- JangSGJeonKSLeeEHKongWSChoJYIsolation of 1′,3′-dilinolenoyl-2′-linoleoylglycerol with tyrosinase inhibitory activity from Flammulina velutipesJ Microbiol Biotechnol200919768168419652515
- IshikawaNKYamajiKTaharaSFukushiYTakahashiKHighly oxidized cuparene-type sesquiterpenes from a mycelial culture of Flammulina velutipesPhytochemistry200054877778211014265
- HsiehKYHsuCILinJYTsaiCCLinRHOral administration of an edible-mushroom-derived protein inhibits the development of food-allergic reactions in miceClin Exper Allergy200333111595160214616874
- KoWCLiuWCTsangYTHsiehCWKinetics of winter mushrooms (Flammulina velutipes) microstructure and quality changes during thermal processingJ Food Engin2007813587598
- LeeKJYunIJKimKHAmino acid and fatty acid compositions of Agrocybe chaxingu, an edible mushroomJ Food Compost Anal2011242175178
- KoganAGartiNMicroemulsions as transdermal drug delivery vehiclesAdv Colloid Interface Sci200612336938516843424
- ConstantinidesPPLipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspectsPharm Res19951211156115728592652
- ShahNHCarvajalMTPatelCIInfeldMHMalickAWSelf-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugsInt J Pharm199410611523
- LawrenceMJReesGDMicroemulsion-based media as novel drug delivery systemsAdv Drug Deliv Rev20004518912111104900
- GaoZGChoiHGShinHJPhysicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin AInt J Pharm199816117586
- YinYMCuiFDMuCFDocetaxel microemulsion for enhanced oral bioavailability: Preparation and in vitro and in vivo evaluationJ Control Release20091402869419709639
- ZhangHCuiYZhuSFengFZhengXCharacterization and antimicrobial activity of a pharmaceutical microemulsionInt J Pharm2010395115416020580790
- FörsterTVon RybinskiWWadleAInfluence of microemulsion phases on the preparation of fine-disperse emulsionsAdv Colloid Interface Sci1995582119149
- LaguesMSautereyCPercolation transition in water in oil microemulsions. Electrical conductivity measurementsJ Phys Chem1980842635033508
- AboofazeliRLawrenceMJInvestigations into the formation and characterization of phospholipid microemulsions. I. Pseudo-ternary phase diagrams of systems containing water-lecithin-alcohol-isopropyl myristateInt J Pharm1993931–3161175
- TrottaMUgazioEGascoMRPseudo-ternary phase diagrams of lecithin-based microemulsions: influence of monoalkylphosphatesJ Pharm Pharmacol19954764514547674125
- RegeBDKaoJPYPolliJEEffects of nonionic surfactants on membrane transporters in Caco-2 cell monolayersEur J Pharm Sci2002164–523724612208453
- LinYShenQKatsumiHEffects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in ratsBiol Pharm Bull20073071301130717603171
- TakahashiYKondoHYasudaTWatanabeTKobayashiSIYokohamaSCommon solubilizers to estimate the Caco-2 transport of poorly water-soluble drugsInt J Pharm20022461859412270611
- ZhangQJiangXJiangWLuWSuLShiZPreparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brainInt J Pharm20042751859615081140
- ChuCTongSXuYProliposomes for oral delivery of dehydrosilymarin: preparation and evaluation in vitro and in vivoActa Pharmacol Sin201132797398021666703
- PitaksuteepongTDaviesNMTuckerIGRadesTFactors influencing the entrapment of hydrophilic compounds in nanocapsules prepared by interfacial polymerisation of water-in-oil microemulsionsEur J Pharm Biopharm200253333534211976022
- YaoitaYAmemiyaKOhnumaHSterol constituents from five edible mushroomsChem Pharm Bull1998466944950
- SuffnessMPezzutoJMAssays related to cancer drug discoveryMethods in Plant Biochemistry: Assays for Bioactivity1990671133
- YasukawaKAokiTTakidoMIkekawaTSaitoHMatsuzawaTInhibitory effects of ergosterol isolated from the edible mushroom Hypsizigus marmoreus on TPA-induced inflammatory ear oedema and tumour promotion in micePhytother Res1994811013
- HuLWuHNiuFYanCYangXJiaYDesign of fenofibrate microemulsion for improved bioavailabilityInt J Pharm2011420225125521907776
- ConstantinidesPPYivSHParticle size determination of phase-inverted water-in-oil microemulsions under different dilution and storage conditionsInt J Pharm19951152225234
- TsaiYHLeeKFHuangYBHuangCTWuPCIn vitro permeation and in vivo whitening effect of topical hesperetin microemulsion delivery systemInt J Pharm20103881–225726220060453
- ShimaMKobayashiYKimuraYAdachiSMatsunoREffect of the hydrophilic surfactants on the preparation and encapsulation efficiency in course and fine W/O/W type emulsionsColloids Surf A Physicochem Eng Asp200423818390
- GannuRPalemCRYamsaniVVYamsaniSKYamsaniMREnhanced bioavailability of lacidipine via microemulsion based transdermal gels: Formulation optimization, ex vivo and in vivo characterizationInt J Pharm20103881–223124120060457
- LiXYueYZhouYAn oil-free microemulsion for intravenous delivery of diallyl trisulfide: Formulation and evaluationInt J Pharm20114071–215816621238561